/ - \
Home
-Experience - Innovation - Persistence
The World's Leading Provider of Cytokine Cell-Based Assays
Welcome
Partnerships Collaborators Careers Contact Us -
Search SBH:    -
-

Oncology

In-Vitro Cytotoxicity Testing
We currently have over 200 mammalian cells with over 150 different cancer cell lines, as well as numerous Primary human cells (e.g., HEKa, HUVEC, HMVEC, NHDF). We already perform hundreds of anticancer drug testing. We can analyze the biological activity of your compound by itself or in combination with known anticancer drug. See below for a full list of anti-cancer drugs currently available.

Please contact us with any request for cell-based Toxicity Testing. We can perform any Non Radioactive Cytotoxicity Assay (e.g. The MultiTox-Glo Multiplex Cytotoxicity Assay, ApoGlow). Moreover, we can order any new cell line and custom develop your assay as per your specific need.

These are the 29 anti-cancer drugs currently available for research purposes at SBH Sciences:

Adrucil - Fluorouracil (5FU)
Artesunate
Artemisinin
Avastin
Bortezomib (Valcade)
Camptothecin
Carboplatin
Cyclophosphamide (Cytoxan)
Cisplatin (data), cisplatinum or
cis- Diamminedichloroplatinum (II)(data)
Dasatinib
Doxorubicin (data)
Erlotinib (data)
Etoposide
Gefitinib (Iressa)
Gemcitabine Hydrochloride
Imatinib (Gleevec)
Irinotecan HCl
Ifosfamide
Leptomycin B
Mitomycin C (data)
Neomycin Sulfate
a-Solanine
Paclitaxel (Taxol)
Sorafenib
Staurosporine
Tamoxifen
Tomatine
Vinblastine
Vincristine

SBH Sciences is actively collaborating with Karyopharm Therapeutics in its anti-cancer development program.

We have used over 60 cancer cell lines in this collaboration and we continuing screening for a potential anti-cancer drug. SBH Sciences and Karyopharm Therapeutics have presented six scientific abstracts together.

Please contact us with your specific needs or any questions related to In-Vitro Oncology investigation and Anti-Cancer lead drug optimization.


-
- - -


The World's Leading Provider of Cytokine Cell-Based Assays

/ - \
- - -